About Prime Medicine
Prime Medicine is a company based in Cambridge (United States) founded in 2019.. Prime Medicine has raised $200 million across 1 funding round from investors including T. Rowe Price, Arch Venture Partners and Newpath Partners. The company has 214 employees as of December 31, 2024. Prime Medicine offers products and services including Prime Editing and Clinical Programs. Prime Medicine operates in a competitive market with competitors including eGenesis, Beam Therapeutics, Korro Bio, Scribe Therapeutics and Tessera Therapeutics, among others.
- Headquarter Cambridge, United States
- Employees 214 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Prime Medicine, Inc.
-
Annual Revenue
$2.98 M0as on Dec 31, 2024
-
Net Profit
$-195.88 M1.14as on Dec 31, 2024
-
EBITDA
$-196.34 M-5.2as on Dec 31, 2024
-
Total Equity Funding
$200 M (USD)
in 1 rounds
-
Latest Funding Round
$200 M (USD), Series B
Jul 13, 2021
-
Investors
T. Rowe Price
& 9 more
-
Employee Count
214
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Prime Medicine
Prime Medicine is a publicly listed company on the NASDAQ with ticker symbol PRME in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Prime Medicine
Prime Medicine offers a comprehensive portfolio of products and services, including Prime Editing and Clinical Programs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for precise DNA correction to treat genetic diseases effectively.
Programs targeting genetic mutations for disease treatment applications.
Unlock access to complete
Unlock access to complete
Funding Insights of Prime Medicine
Prime Medicine has successfully raised a total of $200M through 1 strategic funding round. The most recent funding activity was a Series B round of $200 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $200.0M
-
First Round
First Round
(13 Jul 2021)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Series B - Prime Medicine | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Prime Medicine
Prime Medicine has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include T. Rowe Price, Arch Venture Partners and Newpath Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment management services are offered by Newpath Partners.
|
Founded Year | Domain | Location | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Founded Year | Domain | Location | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Prime Medicine
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Prime Medicine
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Prime Medicine Comparisons
Competitors of Prime Medicine
Prime Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as eGenesis, Beam Therapeutics, Korro Bio, Scribe Therapeutics and Tessera Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Gene transplantation platform for humanizing pig cells is developed.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapy using CRISPR base editing to treat diseases
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
|
| domain | founded_year | HQ Location |
A CRISPR-based gene-editing platform is developed for therapeutic applications.
|
|
| domain | founded_year | HQ Location |
New genome engineering technology is provided for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for infectious disease and inflammatory indications
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Prime Medicine
Frequently Asked Questions about Prime Medicine
When was Prime Medicine founded?
Prime Medicine was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Where is Prime Medicine located?
Prime Medicine is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Prime Medicine a funded company?
Prime Medicine is a funded company, having raised a total of $200M across 1 funding round to date. The company's 1st funding round was a Series B of $200M, raised on Jul 13, 2021.
How many employees does Prime Medicine have?
As of Dec 31, 2024, the latest employee count at Prime Medicine is 214.
What is the annual revenue of Prime Medicine?
Annual revenue of Prime Medicine is $2.98M as on Dec 31, 2024.
What does Prime Medicine do?
Prime Medicine was founded in 2019 in Cambridge, United States, within the biotechnology sector. Genetic therapies are developed by the company to target a broad range of diseases. Next-generation gene editing and prime editing technologies are employed in these operations. The approach is centered on expanding treatment options across various disease categories, with activities based in the United States.
Who are the top competitors of Prime Medicine?
Prime Medicine's top competitors include eGenesis, Tessera Therapeutics and Korro Bio.
What products or services does Prime Medicine offer?
Prime Medicine offers Prime Editing and Clinical Programs.
Is Prime Medicine publicly traded?
Yes, Prime Medicine is publicly traded on NASDAQ under the ticker symbol PRME.
Who are Prime Medicine's investors?
Prime Medicine has 10 investors. Key investors include T. Rowe Price, Arch Venture Partners, Newpath Partners, Google Ventures, and F-Prime Capital.
What is Prime Medicine's ticker symbol?
The ticker symbol of Prime Medicine is PRME on NASDAQ.